ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for alerts Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
Oxurion NV

Oxurion NV (OXUR)

0,2915
0,0005
(0,17%)
Geschlossen 16 November 5:30PM

Ihr Hub für Echtzeit-Streaming-Zitate, Ideen und Live-Diskussionen

Wichtige Statistiken und Details

Current Price
0,2915
Gebot
0,291
Fragen
0,325
Volumen
16.680
0,291 Tagesbereich 0,30
0,0001 52-Wochen-Bereich 1,374
Marktkapitalisierung
Handelsende
0,291
Handelsbeginn
0,2915
Letzte Trade
1500
@
0.2915
Letzter Handelszeitpunkt
Finanzvolumen
-
VWAP
-
Durchschnittliches Volumen (3 Mio.)
7.913.947
Ausgegebene Aktien
3.489.459.000
Dividendenrendite
-
Kurs-Gewinn-Verhältnis
-53,70
Gewinn pro Aktie (EPS)
-0,01
Erlöse
154k
Nettogewinn
-18,97M

Über Oxurion NV

Sektor
Pharmaceutical Preparations
Branche
Pharmaceutical Preparations
Website
Hauptsitz
Leuven, Flemish Brabant, Bel
Gegründet
-
Oxurion NV is listed in the Pharmaceutical Preparations sector of the Euronext with ticker OXUR. The last closing price for Oxurion NV was 0,29 €. Over the last year, Oxurion NV shares have traded in a share price range of 0,0001 € to 1,374 €.

Oxurion NV currently has 3.489.459.000 shares in issue. The market capitalisation of Oxurion NV is 1,02 € billion. Oxurion NV has a price to earnings ratio (PE ratio) of -53.70.

OXUR Neueste Nachrichten

Oxurion Share Consolidation

Oxurion Share Consolidation Oxurion Share Consolidation Leuven, BELGIUM – July 25, 2024 – 06:00 PM CET Oxurion NV (Euronext Brussels: OXUR) (the Company), a biopharmaceutical company based in...

Oxurion Announces Results on the Extraordinary General Meeting (EGM) of 24 July 2024

Oxurion Announces Results on the Extraordinary General Meeting (EGM) of 24 July 2024 Oxurion Announces Results on the Extraordinary General Meeting (EGM) of 24 July 2024 Leuven, BELGIUM – 24 July...

Information on the Total Number of Voting Rights (Denominator) following Conversion Notice from Atlas

Information on the Total Number of Voting Rights (Denominator) following Conversion Notice from Atlas Information on the Total Number of Voting Rights (Denominator) following Conversion Notice...

Oxurion Receives Transparency Notification from Atlas Special Opportunities LLC

Oxurion Receives Transparency Notification from Atlas Special Opportunities LLC Oxurion Receives Transparency Notification from Atlas Special Opportunities LLC Leuven, BELGIUM – July 18, 2024 –...

Oxurion provides clarification on the agenda of the extraordinary general shareholders' meeting to be held on 24 July 2024

Oxurion provides clarification on the agenda of the extraordinary general shareholders' meeting to be held on 24 July 2024 Oxurion provides clarification on the agenda of the extraordinary...

Oxurion signs a Letter of Intent and enters into exclusive negotiations to potentially acquire a pioneering French CRO in stem cell production

Oxurion signs a Letter of Intent and enters into exclusive negotiations to potentially acquire a pioneering French CRO in stem cell production Oxurion signs a Letter of Intent and enters into...

Oxurion announces the results of the Extraordinary General Meeting (EGM) held on 4 July 2024 and convenes a new EGM on 24 July 2024

Oxurion announces the results of the Extraordinary General Meeting (EGM) held on 4 July 2024 and convenes a new EGM on 24 July 2024 Oxurion announces the results of the Extraordinary General...

Oxurion Receives Transparency Notification from Atlas Special Opportunities LLC

Oxurion Receives Transparency Notification from Atlas Special Opportunities LLC Oxurion Receives Transparency Notification from Atlas Special Opportunities LLC Leuven, BELGIUM – June 7, 2024...

Oxurion Announces Extraordinary General Shareholders’ Meeting

Oxurion Announces Extraordinary General Shareholders’ Meeting Oxurion Announces Extraordinary General Shareholders’ Meeting Leuven, BELGIUM – June 4, 2024 – 07:00 PM CET – Oxurion NV...

Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
1-0.0085-2.833333333330.30.30.28169440.28595486DE
4-0.0045-1.520270270270.2960.34450.28184460.29678153DE
120.29142914000.00011.3740.000179139470.00138469DE
260.29142914000.00011.3740.0001394495040.00021844DE
520.2905290500.0011.3740.0001606855250.00021672DE
156-1.9085-86.752.22.230.0001293808470.00400578DE
260-2.4285-89.28308823532.723.70.0001187757790.00643898DE
  • Volumen
  • % Tops
  • % Flops
SymbolPreisVol.
CYADCelyad Oncology SA
0,685 €
(52,22%)
218,11k
ALSPWSpineway
0,13 €
(24,28%)
2,28M
ALARFAdeunis
0,698 €
(21,18%)
6,69k
PARROParrot
2,32 €
(18,07%)
72,18k
MLCOUCourbet
1,35 €
(14,41%)
12,37k
EBUSREbusco
0,16 €
(-57,89%)
854,44k
ATODSAtos SE
0,0122 €
(-21,79%)
5,85M
ALUNTUniti
1,19 €
(-20,13%)
1,03k
MLAAHAmatheon Agri Holding NV
0,02 €
(-20,00%)
69,83k
SGROSegro Plc
9,20 €
(-18,58%)
3
ALNEVNeovacs
0,0002 €
(0,00%)
50,39M
BCPBanco Comercial Portugues SA
0,4447 €
(0,47%)
37,68M
ATOAtos SE
0,2122 €
(11,98%)
13,71M
INGAING Groep NV
14,978 €
(0,96%)
10,99M
KPNKoninklijke KPN NV
3,524 €
(-0,51%)
9,89M
Keine Diskussionen Gefunden.
Neuen Thread Erstellen

Kürzlich von Ihnen besucht

Delayed Upgrade Clock